TrialJournal of the Pediatric Infectious Diseases Society2023

Double-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for Clostridioides difficile Infection (MODIFY III).

Thomas J Sferra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.